Device Trial Radar · NCT05959473
EGFR_IUO 3.20 Clinical Study Protocol
Last checked: Nov 20, 2026Latest source record: Jan 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Sep 2023
Primary completion
Dec 18, 2023
Study completion Dec 18, 2023
Sponsor
- Lead sponsor
- Biocartis NVNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- AstraZeneca
- First posted
- Jul 25, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An interventional, prospective clinical performance study protocol, for the testing of DNA extracted from FFPE Fine needle aspirate samples, using the Idylla EGFR\_IUO/3.20, from patients with Non-Small Cell Lung Cancer screened in AstraZeneca's NeoADAURA clinical trial (Protocol No. D516AC00001)
Conditions
- NSCLC
Interventions
Idylla EGFR_IUO/3.20 Mutation TestDevice
Clinical Performance Study Protocol for Idylla EGFR\_IUO/3.20 Mutation Test The EGFR\_IUO/3.20 is automated on the Idylla™ Platform, which executes the entire process from sample to result including sample liquefaction, cell lysis, real-time PCR amplification/detection, and data analysis and reporting.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Outcome MeasureTime frame: 7 business days
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.